Biliary stent graft GORE® VIATORR® TIPS

ePTFE

For patients with portal hypertension, including those with variceal bleeding and refractory ascites, the GORE® VIATORR® TIPS Endoprosthesis has been improving patient outcomes for more than 20 years. The VIATORR® Device has proven patency1 and patients treated with the VIATORR® Device have a higher one-year survival than those treated with non-TIPS therapy. Purpose-built for TIPS Controlled expansion sleeve is designed to provide intraoperative adjustability of the diameter between 8 mm and 10 mm.* Designed to reach a targeted portal pressure gradient to meet the specific needs of the patient. Lasting diameter control. Size and set the diameter to stay.* Bile-resistant, ePTFE lining designed to sustain patency due to reduced in-stent stenosis. Uncovered portion for sustained portal vein and shunt perfusion. Optimized radial force and flexibility engineered for conformability in tortuous anatomy. Covered stent grafts offer long-term patency, compared to bare metal stents Studies reveal that, at the time of TIPS creation, ePTFE-covered stent grafts have shown improved patency, ascites control and rebleeding prevention, compared to bare metal stents. For patients undergoing TIPS placement, the Advancing Liver Therapeutic Approaches (ALTA) group recommends, "The use of an ePTFE-lined stent graft with controlled expansion, which allows the operator to tailor the amount of portosystemic shunting based on the indication, target gradient and patient comorbidities." Variceal bleeding outcomes Early TIPS compared to drug therapy plus endoscopic band litigation (EBL) for variceal bleeding13